Leaderboard

En | De
Sie sind hier: Gynäkologie » Mammae 07. November 2026
Suchen
medline.ch
Mammae
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Fortpflanzung
Genitale Erkrankungen
Infertilität
Mammae
Menopause
Schwangerschaft
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 11194  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 223866  
   
Men's Self-Reported Knowledge and Awareness Towards Male Breast Cancer in Saudi Arabia: A Cross-Sectional Study.
Cancer Control
Alfageh BH, Alharbi AM, Bin Saab R, Jokhab S, Kalagi NA, Almoghirah H, Alkofide H.
PMID: 42993095 [PubMed - indexed for MEDLINE]


Global Burden and Risk Factors of Breast Cancer in Female Adolescents and Young Adults, 1990-2021: Results from the Global Burden of Disease Study 2021.
Balkan Med J
Su Y, Wen F, Hu J, Yang Y, Wang Y.
PMID: 42992848 [PubMed - as supplied by publisher]


Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05.
Future Oncol
Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, Martins de Aquino Pimentel LC, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Muelle V, Yang S, Granata G, Shen Q, Hamilton E.
PMID: 42992631 [PubMed - as supplied by publisher]


The effectiveness of virtual reality-assisted relaxation therapy in improving psychological symptoms and fatigue of breast cancer survivors: a systematic review and meta-analysis.
Front Oncol
Deng Y, Chen Y, Mo J, Liang Y, Yu S, Bai X.
PMID: 42992359 [PubMed]


Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials.
JCO Oncol Adv
Felsheim BM, Huober J, Carey LA, Nekljudova V, Karn T, Tolaney SM, Schneeweiss A, Untch M, Salat C, Kuzma CS, Fernandez-Martinez A, Rachakonda S, Ponce-Lorenzo JJ, Zahm DM, Suresh R, Stover DG, Rastogi P, Darsow M, Lake DE, Rugo HS, O'Shaughnessy J, Golshan M, Pfefferle AD, Sikov WM, Metzger O, Denkert C, Geyer CE Jr, Perou CM, Loibl S.
PMID: 42992319 [PubMed]


Redefining axillary management by selecting patients for omission of sentinel lymph node surgery in early breast cancer.
Explor Target Antitumor Ther
Tjalma W, Coenen S.
PMID: 42992311 [PubMed]


Lived experiences of psychosocial and quality of life outcomes for adults newly diagnosed with breast cancer in interior British Columbia: qualitative research.
Front Glob Womens Health
D'Souza MS, Manish A, Nette H, Bacsu JR.
PMID: 42991539 [PubMed]


Zero echo time versus T1-weighted gradient-recalled echo MRI of breast biopsy markers: a phantom study comparing susceptibility artifact volume and geometric dimensions.
Transl Breast Cancer Res
Al Masud A, Chartier SR, Nwachukwu CT, Langenfeld ID, Trzasko JD, Johnson JE, Hesley GK, Urban MW, Lee CU.
PMID: 42991485 [PubMed]


Non-malignant breast cancer-related breast edema: an overview.
Transl Breast Cancer Res
Deehan E, Harb R, Mayrovitz H.
PMID: 42991475 [PubMed]


The vascular-immune interface in breast cancer: normalization strategies, combination therapy, and biomarkers.
Front Oncol
Zhang Y, Yulan C, Long K, Wang Q, Liu C, Zeng F.
PMID: 42991471 [PubMed]


Benefits and adverse events of combined chemotherapy and immune checkpoint inhibition in non-metastatic triple-negative breast cancer: a systematic review and an updated meta-analysis.
Transl Breast Cancer Res
Wu J, Zhang K.
PMID: 42991457 [PubMed]


Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial.
Transl Breast Cancer Res
Zhang S, Zhao J, Ling X, Mo X, Li M, Yao H, Jiang Z.
PMID: 42991455 [PubMed]


Multi-omics of tertiary lymphoid structures in breast cancer: clinical significance and biomarker potential.
Front Immunol
Chen C, Song H.
PMID: 42991413 [PubMed - indexed for MEDLINE]


Granulomatous lobular mastitis: diagnostic and prognostic biomarkers.
Front Immunol
Yang X, Li J, Liang H.
PMID: 42991375 [PubMed - indexed for MEDLINE]


Evaluating the Goldilocks Technique for Breast Reconstruction in High-BMI Patients: A Systematic Review of Complications and Patient Satisfaction.
Plast Surg (Oakv)
Kiehn S, Chang A, Knauer G, Mejia N, Bauman S, Mandalapu S, Patel SA, Walchak A.
PMID: 42991347 [PubMed - as supplied by publisher]


Immune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation.
Front Immunol
Zeng L, Wu H, Xue S, Chen M, Song J, Lin W.
PMID: 42991081 [PubMed - indexed for MEDLINE]


Antibody-drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities.
Front Immunol
Fang L, Song J, Wang X, Wang F, Zhu X.
PMID: 42991053 [PubMed - indexed for MEDLINE]


Predictive value of preoperative [18F]FDG PET/CT imaging parameters for postoperative recurrence and metastasis in breast cancer patients.
Front Oncol
Lin N, Ren C, Wen Z.
PMID: 42990977 [PubMed]


SensReg: A Regulon-Based Predictor of Neoadjuvant Chemotherapy Response in ER- Positive/HER2-Negative Breast Cancer.
Res Sq
Lawal B, Wang X.
PMID: 42990800 [PubMed]


Physical activity and breast cancer in the Multiethnic Cohort Study.
Res Sq
Gill JK, Holm C, Park SY, Shvetsov Y, Haiman C, Wilkens LR, LeMarchand L, Maskarinec G.
PMID: 42990784 [PubMed]


   
   Artikel 1 - 20 / 223866    Seite 1 von 11194  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1